1-Bromopropane → N,N-Dipropyl-2,5-dimethyl-3-(2,4,6-trimethylphenyl)-2H-pyrazolo[4,3-d]pyrimidin-7-amine

HRID 1266153

반응식

HRID 1266153 반응식
[CH2:1]([NH:4][C:5]1[C:6]2[C:7](=[C:12]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][C:17]=3[CH3:24])[N:13]([CH3:15])[N:14]=2)[N:8]=[C:9]([CH3:11])[N:10]=1)[CH2:2][CH3:3].[OH-].[K+].Br[CH2:28][CH2:29][CH3:30]>CS(C)=O>[CH2:1]([N:4]([CH2:28][CH2:29][CH3:30])[C:5]1[C:6]2[C:7](=[C:12]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][C:17]=3[CH3:24])[N:13]([CH3:15])[N:14]=2)[N:8]=[C:9]([CH3:11])[N:10]=1)[CH2:2][CH3:3]

참가 물질

5

반응 조건

온도
60 °C

실험 절차

A mixture of the product of step F (400 mg, 1.2 mmol), powder KOH (1.0 g) and 1-bromopropane (1 mL) in 2 mL of DMSO was heated at 60° C. for 8 hours. The excess bromopropane was then evaporated. The mixture was partitioned between water and ether. The aqueous layer was separated and extracted with ether. The combined ether extracts were washed with water and brine, dried over Na2SO4 and concentrated to an oil. The oil was purified through silica gel column chromatography to give 260 mg of the title compound as an oil. 1H NMR (CDCl3): d 0.97 (t, 6 H), 1.76 (m, 4 H), 1.96 (s, 6 H), 2.32 (s, 3 H), 2.45 (s, 3 H), 3.77 (s, 3 H), 3.40-4.30 (br, 4 H), 6.95 (s, 2 H)ppm. The hydrochloride salt prepared in Ether/HCl melted at 210-13° C.

후처리

  1. customThe excess bromopropane was then evaporated
  2. customThe mixture was partitioned between water and ether
  3. customThe aqueous layer was separated
  4. extractionextracted with ether
  5. washThe combined ether extracts were washed with water and brine
  6. dry with materialdried over Na2SO4
  7. concentrationconcentrated to an oil
  8. customThe oil was purified through silica gel column chromatography

출처 및 근거

ORD 기록
ord-c0ddee485f1342df91b04a4e5a06d480
출처 데이터셋
uspto-grants-2003_04
특허 번호
US06548509B2

연결된 노트

불러오는 중…